A ChatGPT clone can now design whole genomes from scratch
When it comes to designing the code of life and new organisms AI's increasingly on it ...
Key takeaways
- Rather than training Evo on content scraped from the internet, they trained the AI on nearly three million genomes - amounting to billions of lines of genetic code - from various microbes and bacteria-infecting viruses.
- Compared to the English alphabet’s 26 letters, DNA only has A, T, C, and G.
- Compared to GPT-4 and other AI models, StripedHyena is designed to be faster and more capable of processing large inputs - for example, long lengths of DNA.
Cite or link to this article
Griffin, M. (2024) 'A ChatGPT clone can now design whole genomes from scratch', 311 Institute, 21 November. Available at: https://www.311institute.com/a-chatgpt-clone-can-now-design-whole-genomes-from-scratch/ (Accessed: 1 October 2026).
All life on Earth is written with four DNA “letters” – unless that is we count in Synthetic DNA which can have up to 11 letters. But now an Artificial Intelligence (AI) just used those four letters to dream up a completely new genome from scratch – and it’s not the first time this has happened. Called Evo, the AI was inspired by the large language models, or LLMs, underlying popular chatbots such as OpenAI’s ChatGPT and Anthropic’s Claude - which is also now starting to show the basic signs of self-awareness. These models have taken the world by storm for their prowess at generating human-like responses. From simple tasks, such as defining an obtuse word, to summarizing scientific papers or spewing verses fit for a rap battle, LLMs have entered our everyday lives.
If LLMs can master written languages - could they do the same for the language of life?
This month, a team from Stanford University and the Arc Institute put the theory to the test. Rather than training Evo on content scraped from the internet, they trained the AI on nearly three million genomes - amounting to billions of lines of genetic code - from various microbes and bacteria-infecting viruses.
Evo was better than previous AI models at predicting how mutations to genetic material - DNA and RNA - could alter function. The AI also got creative, dreaming up several new components for the gene editing tool, CRISPR. Even more impressively, the AI generated a genome more than a megabase long - roughly the size of some bacterial genomes.
“Overall, Evo represents a genomic foundation model,” wrote Christina Theodoris at the Gladstone Institute in San Francisco, who was not involved in the work.
Having learned the genomic vocabulary, algorithms like Evo could help scientists probe evolution, decipher our cells’ inner workings, tackle biological mysteries, and fast-track synthetic biology by designing complex new bio-molecules.
Compared to the English alphabet’s 26 letters, DNA only has A, T, C, and G. These ‘letters’ are shorthand for the four molecules - adenine (A), thymine (T), cytosine (C), and guanine (G) - that, combined, spell out our genes. If LLMs can conquer languages and generate new prose, rewriting the genetic handbook with only four letters should be a piece of cake.
Not quite. Human language is organized into words, phrases, and punctuated into sentences to convey information. DNA, in contrast, is more continuous, and genetic components are complex. The same DNA letters carry “parallel threads of information,” wrote Theodoris.
The most familiar is DNA’s role as genetic carrier. A specific combination of three DNA letters, called a codon, encodes a protein building block. These are strung together into the proteins that make up our tissues, organs, and direct the inner workings of our cells.
But the same genetic sequence, depending on its structure, can also recruit the molecules needed to turn codons into proteins. And sometimes, the same DNA letters can turn one gene into different proteins depending on a cell’s health and environment or even turn the gene off.
In other words, DNA letters contain a wealth of information about the genome’s complexity. And any changes can jeopardize a protein’s function, resulting in genetic disease and other health problems. This makes it critical for AI to work at the resolution of single DNA letters.
But it’s hard for AI to capture multiple threads of information on a large scale by analyzing genetic letters alone, partially due to high computational costs. Like ancient Roman scripts, DNA is a continuum of letters without clear punctuation. So, it could be necessary to “read” whole strands to gain an overall picture of their structure and function - that is, to decipher meaning.
Previous attempts have “bundled” DNA letters into blocks - a bit like making artificial words. While easier to process, these methods disrupt the continuity of DNA, resulting in the retention of “some threads of information at the expense of others,” wrote Theodoris.
Evo addressed these problems head on. Its designers aimed to preserve all threads of information, while operating at single-DNA-letter resolution with lower computational costs.
The trick was to give Evo a broader context for any given chunk of the genome by leveraging a specific type of AI setup used in a family of algorithms called StripedHyena. Compared to GPT-4 and other AI models, StripedHyena is designed to be faster and more capable of processing large inputs - for example, long lengths of DNA. This broadened Evo’s so-called “search window,” allowing it to better find patterns across a larger genetic landscape.
The researchers then trained the AI on a database of nearly three million genomes from bacteria and viruses that infect bacteria, known as phages. It also learned from plasmids, circular bits of DNA often found in bacteria that transmit genetic information between microbes, spurring evolution and perpetuating antibiotic resistance.
Once trained, the team pitted Evo against other AI models to predict how mutations in a given genetic sequence might impact the sequence’s function, such as coding for proteins. Even though it was never told which genetic letters form codons, Evo outperformed an AI model explicitly trained to recognize protein-coding DNA letters on the task.
Remarkably, Evo also predicted the effect of mutations on a wide variety of RNA molecules- for example, those regulating gene expression, shuttling protein building blocks to the cell’s protein-making factory, and acting as enzymes to fine-tune protein function.
Evo seemed to have gained a “fundamental understanding of DNA grammar,” wrote Theodoris, making it a perfect tool to create “meaningful” new genetic code.
To test this, the team used the AI to design new versions of the gene editing tool CRISPR. The task is especially difficult as the system contains two elements that work together - a guide RNA molecule and a pair of protein “scissors” called Cas. Evo generated millions of potential Cas proteins and their accompanying guide RNA. The team picked 11 of the most promising combinations, synthesized them in the lab, and tested their activity in test tubes.
One stood out. A variant of Cas9, the AI-designed protein cleaved its DNA target when paired with its guide RNA partner. These designer biomolecules represent the “first examples” of codesign between proteins and DNA or RNA with a language model, wrote the team.
The team also asked Evo to generate a DNA sequence similar in length to some bacterial genomes and compared the results to natural genomes. The designer genome contained some essential genes for cell survival, but with myriad unnatural characteristics preventing it from being functional. This suggests the AI can only make a “blurry image” of a genome, one that contains key elements, but lacks finer-grained details, wrote the team.
Like other LLMs, Evo sometimes “hallucinates,” spewing CRISPR systems with no chance of working. Despite the problems, the AI suggests future LLMs could predict and generate genomes on a broader scale. The tool could also help scientists examine long-range genetic interactions in microbes and phages, potentially sparking insights into how we might rewire their genomes to produce biofuels, plastic-eating bugs, or medicines.
It’s yet unclear whether Evo could decipher or generate far longer genomes, like those in plants, animals, or humans. If the model can scale, however, it “would have tremendous diagnostic and therapeutic implications for disease,” wrote Theodoris.
FAQ
Why does this matter?
When it comes to designing the code of life and new organisms AI's increasingly on it ...

About the author
Matthew Griffin Founder, 311 Institute
Matthew Griffin is a multi-award winning Futurist and expert in Disruption and Innovation, Geopolitics, Leadership, and Technology, who NASA have described as a "walking encyclopaedia of the future" and a "futurist Polymath."
Read full bio
Matthew Griffin is a multi-award winning Futurist and expert in Disruption and Innovation, Geopolitics, Leadership, and Technology, who NASA have described as a "walking encyclopaedia of the future" and a "futurist Polymath." 15-time best selling author of the "Codex of the Future" series, Matthew is the Founder and Futurist in Chief of the 311 Institute, a global Futures and Deep Futures advisory firm working with royal households, world leaders, G7, G20, and G77 governments, NGOs, and multi-national mid and mega cap firms to help them explore, shape, and lead the next 50 years of business and society.
An award-winning YouTube creator with over a million followers, with an unrivalled global reach and impact, Matthew is a highly sought-after international keynote speaker, lecturer, and mentor who collaborates with global leaders through the United Nations Alliance of Civilizations (UNAOC) and United Nations General Assembly (UNGA) to shape pivotal initiatives such as the UN’s AI for Humanity program, the United Nations Conference of the Parties (UN COP), and the World Economic Forum in Davos.
As the former Global Head of Cloud, National Security, and Enterprise Sales for companies including Atos, Dell-EMC, and IBM, Matthew has a proven track record of building multi-billion dollar business units and turning failing divisions into market leaders. His ability to identify, analyse, and communicate the implications of hundreds of emerging technologies and trends is unparalleled, and his insights are trusted by many of the world’s most respected organisations, including ABB, Accenture, Adidas, AON, ARM, BCG, Centrica, Citi, Coca-Cola, Dentons, Deloitte, Dow Jones, EY, Google, KPMG, Lego, Legal & General, LinkedIn, Microsoft, PepsiCo, Qualcomm, RWE, Samsung, Siemens AG and Siemens Energy, T-Mobile, UBS, VISA, Walmart, Workday, Worldpay and many others.
Regularly featured in the global media including the AP, BBC, Bloomberg, CNBC, Discovery, Forbes, Khaleej Times, Telegraph, TIME, ViacomCBS, WIRED, and the WSJ, Matthews mission is to help organisations create a fair and sustainable future whose benefits are shared by everyone irrespective of their ability, background, or circumstances.
What future do you need to see?
Choose one to get started on biotech and enhanced humans and the future of your organisation.
Sources and further reading
- Science.ado9336 science.org
- Science.adt3007 science.org
- 2023.06.12.544594v1 biorxiv.org
- S41467 024 46947 9 nature.com
- 2023.01.11.523679v1 biorxiv.org
- a specific type of AI setup the-decoder.com
Source: first published by the 311 Institute on 21 November 2024. Cite as: Griffin, M. (2024). A ChatGPT clone can now design whole genomes from scratch. 311 Institute. https://www.311institute.com/a-chatgpt-clone-can-now-design-whole-genomes-from-scratch/
You are welcome to quote this article with credit and a link to the original.